Export 14 results:
Author Title [ Type(Asc)] Year
Filters: Author is Balasubramanian, Poonkuzhali  [Clear All Filters]
Journal Article
Ganesan S, Palani HKumar, Lakshmanan V, Balasundaram N, Alex AAbu, David S, Venkatraman A, Korula A, George B, Balasubramanian P, Palakodeti D, Vyas N, Mathews V.  2019.  Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.. Cell Death Dis. 10(10):736. DOI:10.1038/s41419-019-1964-8.
Rajamani BM, Illangeswaran RStephen St, Benjamin ESathya Bam, Balakrishnan B, Jebanesan DZechariah, Das S, Pai AAnand, Vidhyadharan RThalayattu, Mohan A, Karathedath S, Abraham A, Mathews V, Velayudhan SR, Balasubramanian P.  2023.  Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib and reduces disease burden .. Front Pharmacol. 14:1187066. DOI:10.3389/fphar.2023.1187066.
Balakrishnan B, Illangeswaran RStephen St, Rajamani BMurugan, Arunachalam AKumar, Pai AAnand, Mohanan E, Srivastava A, Mathews V, Balasubramanian P.  2023.  Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.. PLoS One. 18(10):e0293311. DOI:10.1371/journal.pone.0293311.
Benjamin ESathya Bam, Vinod E, Illangeswaran RStephen St, Rajamani BM, Vidhyadharan RThalayattu, Bagchi A, Maity A, Mohan A, Parasuraman G, Amirtham SManickam, Abraham A, Velayudhan SR, Balasubramanian P.  2024.  Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.. Cell Signal. 116:111067. DOI:10.1016/j.cellsig.2024.111067.
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, Rajendiran V, Syedbasha N, Pai AAnand, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR et al..  2022.  Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.. Elife. 11 DOI:10.7554/eLife.65421.
Bagchi A, Devaraju N, Chambayil K, Rajendiran V, Venkatesan V, Sayed N, Pai AAnand, Nath A, David E, Nakamura Y, Balasubramanian P, Srivastava A, Thangavel S, Mohankumar KM, Velayudhan SR.  2022.  Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications.. Sci Rep. 12(1):14033. DOI:10.1038/s41598-022-13783-0.
Ijee S, Chambayil K, Chaudhury ADutta, Bagchi A, Modak K, Das S, Benjamin ESathya Bam, Rani S, Paul DZechariah, Nath A, Roy D, Palani D, Priyanka S, Ravichandran R, Kumary BK, Sivamani Y, S V, Babu D, Nakamura Y, Thamodaran V et al..  2023.  Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.. Front Mol Biosci. 10:1295507. DOI:10.3389/fmolb.2023.1295507.
George A, Ravi NSam, Prasad K, Panigrahi L, Koikkara S, Rajendiran V, Devaraju N, Paul J, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, Mohankumar KM.  2022.  Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2.. Front Genome Ed. 4:1085111. DOI:10.3389/fgeed.2022.1085111.
Venkatesan V, Christopher ACrystal, Rhiel M, Azhagiri MKumar K, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S, Karuppusamy KV, Jacob A, Bagchi A, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Pai R, Marepally SKumar, Mohankumar KMurugesan et al..  2023.  Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.. Mol Ther Nucleic Acids. 32:671-688. DOI:10.1016/j.omtn.2023.04.024.
Bagchi A, Nath A, Thamodaran V, Ijee S, Palani D, Rajendiran V, Venkatesan V, Datari P, Pai AAnand, Janet NBeryl, Balasubramanian P, Nakamura Y, Srivastava A, Mohankumar KMurugesan, Thangavel S, Velayudhan SR.  2021.  Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells.. Cells. 10(3) DOI:10.3390/cells10030523.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].. Leuk Res. 130:107329. DOI:10.1016/j.leukres.2023.107329.
Maddila SChandar, Voshavar C, Arjunan P, Chowath RPrakash, Rachamalla HKrishna Re, Balakrishnan B, Balasubramanian P, Banerjee R, Marepally S.  2021.  Cholesterol Sequestration from Caveolae/Lipid Rafts Enhances Cationic Liposome-Mediated Nucleic Acid Delivery into Endothelial Cells.. Molecules. 26(15) DOI:10.3390/molecules26154626.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.. Leuk Res. 128:107054. DOI:10.1016/j.leukres.2023.107054.
Rajendiran V, Devaraju N, Haddad M, Ravi NSam, Panigrahi L, Paul J, Gopalakrishnan C, Wyman S, Ariudainambi K, Mahalingam G, Periyasami Y, Prasad K, George A, Sukumaran D, Gopinathan S, Pai AAnand, Nakamura Y, Balasubramanian P, Ramalingam R, Thangavel S et al..  2024.  Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.. Mol Ther. 32(3):663-677. DOI:10.1016/j.ymthe.2024.01.023.